Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review.
- Published in:
- BioDrugs, 2017, v. 31, n. 1, p. 37, doi. 10.1007/s40259-016-0206-1
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2017 AND VI 31 AND IP 1
Results: 5
1
2
Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence.
- Published in:
- BioDrugs, 2017, v. 31, n. 1, p. 1, doi. 10.1007/s40259-016-0207-0
- By:
- Publication type:
- Article
3
Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of Care.
- Published in:
- BioDrugs, 2017, v. 31, n. 1, p. 51, doi. 10.1007/s40259-016-0208-z
- By:
- Publication type:
- Article
4
Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients.
- Published in:
- BioDrugs, 2017, v. 31, n. 1, p. 75, doi. 10.1007/s40259-016-0209-y
- By:
- Publication type:
- Article
5
HER3 as a Therapeutic Target in Cancer.
- Published in:
- BioDrugs, 2017, v. 31, n. 1, p. 63, doi. 10.1007/s40259-016-0205-2
- By:
- Publication type:
- Article